Company intelligence / Profile preview

FUJIFILM Cellular Dynamics

Madison, Wisconsin, USAfujifilmcdi.com ↗

Ownership: Private
Employees: ~220
Development stage: Other

Overview

FCDI has developed a robust iPSC platform for generating human cell types at scale. The company supplies these for research use worldwide and supports partners with cGMP manufacturing of clinical-grade iPSC-derived therapies. Its cardiovascular progenitor cell-derived extracellular vesicle product entered an investigator-sponsored clinical trial in non-ischemic heart failure in Europe. Other therapeutic areas are at preclinical or IND-enabling stages.

Therapeutic areas: OncologyCardiovascularOphthalmologyNeurology
Modalities: Induced pluripotent stem cell derived therapyCell therapyStem cell therapy
Industry: Biotech

Drug pipeline

1 asset

OpCT-003

Preclinical

Partnerships

Assistance Publique – Hôpitaux de Paris/AP–HP

Beyond the preview

Go deeper on FUJIFILM Cellular Dynamics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FUJIFILM Cellular Dynamics.

Explore the full profile